big pharma Latest News

Today’s pharmaceutical industry faces unprecedented challenges. Our latest research report explores the key challenges facing pharma companies and includes case studies to provide context on the industry’s challenges.

Bioinformatics Partnering Terms and Agreements Report - This report provides details of the latest bioinformatics agreements announced in the healthcare sectors.

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics Report

Healthcare IT Market to 2016 - Demand for Integration of Advanced Clinical Applications to Drive the Market Report

Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry Report

Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth Report

Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013 Report

North America Diabetes Care Devices Market Outlook to 2016 Report

New Research into Prescribing Practices Report-This report reviews the role of CER intelligence, the significant gaps it has identified in physician knowledge and how CER information will shape the way that pharmaceutical firms promote their products

MSL-KOL Engagement: Ensuring Compliance Report - This report examines how MSLs are being used to engage physicians in a way that traditional sales no longer can.

This report includes a compilation of current active projects in research and development of antibody-drug conjugates and other immunoconjugates in oncology.

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics Report

Digital Marketing Talent: Who Is Pharma Hiring? - This report goes behind the doors of HR departments and recruitment firms to examine the current job market in digital marketing.

The Impact of iPads on Pharma: a Primer Report - This report provides complete insight into how the iPad is being used and why.

The State of the Central Labs Market Report - This report provides views to outsourcing and service provider selection strategies as well as spending for central labs services.

The State of the EDC and ePRO Market Report - This report contains the following four sections: High-level takeaways and implications, EDC service provider section, ePRO service provider section and Trends and ideas impacting clinical development

Patient and Investigator Recruitment Success Report - This report provides detail the drivers and barriers to successfully recruiting patients and investigators into clinical trials.

Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics Report

Late Phase Market Dynamics Report - This report contains the following three sections: Late Phase Trends and Market Sizing, Service Provider Dynamics and Decision Making for Late Phase Studies

Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics Report

CHI’s Oncology Clinical Trials: Bringing Effective and Safe Cancer Therapy to Patient takes place Feb. 13-15, 2013 at the Moscone in San Francisco, CA. This conference is part of the many program options available at the Molecular Med TRI-CON 2013.

Today’s pharmaceutical industry faces unprecedented challenges. Our latest research report explores the key challenges facing pharma companies and includes case studies to provide context on the industry’s challenges.

Bioinformatics Partnering Terms and Agreements Report - This report provides details of the latest bioinformatics agreements announced in the healthcare sectors.

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics Report

Healthcare IT Market to 2016 - Demand for Integration of Advanced Clinical Applications to Drive the Market Report

Cross-Border M&A Activity In Pharmaceutical & Healthcare Industry Report

Coagulation Factors 2011 – Who Does Meet The Market Needs? A Pipeline Assessment, Market Survey and Corporate Benchmark Analysis Report

Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth Report

Biomarker Partnering Terms and Agreements Report - This report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies.

Emerging Pharmaceutical Market in China - Forecast to Become The World’s Third-Largest Pharmaceutical Market By 2013 Report

Drug Combinations: New Rules, New Opportunities Report - This report provides the guidance offered by the FDA, and explains how it can be deployed to develop effective new treatments.

North America Diabetes Care Devices Market Outlook to 2016 Report

New Research into Prescribing Practices Report-This report reviews the role of CER intelligence, the significant gaps it has identified in physician knowledge and how CER information will shape the way that pharmaceutical firms promote their products

MSL-KOL Engagement: Ensuring Compliance Report - This report examines how MSLs are being used to engage physicians in a way that traditional sales no longer can.

Market Access Europe: It's Not Just About Price Report - This report addresses all major areas of market access in Europe, from value demonstration and partnership to price reference issues and the importance of communicating value.

This report includes a compilation of current active projects in research and development of antibody-drug conjugates and other immunoconjugates in oncology.

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics Report

Digital Marketing Talent: Who Is Pharma Hiring? - This report goes behind the doors of HR departments and recruitment firms to examine the current job market in digital marketing.

The Impact of iPads on Pharma: a Primer Report - This report provides complete insight into how the iPad is being used and why.

The State of the Central Labs Market Report - This report provides views to outsourcing and service provider selection strategies as well as spending for central labs services.

The State of the EDC and ePRO Market Report - This report contains the following four sections: High-level takeaways and implications, EDC service provider section, ePRO service provider section and Trends and ideas impacting clinical development

Patient and Investigator Recruitment Success Report - This report provides detail the drivers and barriers to successfully recruiting patients and investigators into clinical trials.

Pharmaceutical Brand PR: Developing Engaging Campaigns and Measuring ROI Report

Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics Report

Late Phase Market Dynamics Report - This report contains the following three sections: Late Phase Trends and Market Sizing, Service Provider Dynamics and Decision Making for Late Phase Studies

Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics Report

Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Report

Respiratory Distress Syndrome – Pipeline Review Report - This report provides information on the therapeutic development for Respiratory Distress Syndrome, complete with latest updates, and special features on late-stage and discontinued projects.

Diabetes Care Devices Global Market Briefing to 2016 Report - This report provides market landscape, competitive landscape and market trends information the diabetes care devices market.

Competitor Analysis: HIV Small Molecule Therapeutics Report - This report includes a compilation of marketed products and currently active projects in research and development of HIV Small Molecule Therapeutics.

Clinical Development Staff Quality & Resourcing Models Report

Biopharma Outsourcing Performance Report This report examines the outsourcing relationship from the CRO's perspective and benchmarks many sponsor companies' outsourcing operations and practices.

Biosimilars: Surveying the Market Landscape Report - This report reviews all aspects of biosimilar production, from manufacturing and marketing to the regulatory landscape.

Licensing Strategies of Large Pharmaceutical Companies - Weak R&D Pipelines and the Patent Cliff Stimulate In-Licensing Activity Report

Antibody-Drug Conjugates 2011 – real breakthrough still to come: a Technology, Stakeholder and R&D Pipeline Analysis Report

Hematological Cancer Therapies: Pipelines, Markets, and Business Considerations

Technical Expertise, Potential for Time and Cost Savings Underlines Viability of Contract Outsourcing

New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD

New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

View IPR’s Most Recent Report Titles from the 2011 Catalog and Our Newly Launched Insight Update Series.

New Report Finds Global Biotechnology Industry Poised for Massive 5-Year Growth

The inability of the medical profession to actually think about what they are doing when they prescribe medications is highlighted by a new study warning that much of the blood pressure medication given may actually be making blood pressure worse.

While this report looks at the entire Phama R&D pipeline to 2015, a key focus is the increasing role of biopharmaceutical products.

A ‘Top 10’ pharmaceutical company is one of the first to implement Debra 5.7.7, the latest release of LabLogic Systems’ LIMS for drug metabolism studies.

A nightmarish story of two week old twins of Dennis Quaid and Kimberley Buffington, getting overdosed by a 1000 times overdose of blood thinner Heparin* at LA Cedars Sinai Hospital (*already under scrutiny for Chinese manufacturing contamination)